BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Infographics: Dynamic digital data analysis
BioWorld 2024 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Israel
Rise of obesity
Radiopharmaceuticals
Biosimilars
Aging
IVDs on the rise
Coronavirus
Artificial intelligence
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Friday, December 27, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
April 22, 1997
View Archived Issues
Teva receives FDA approval for antihypertensive generic
Read More
Orally active antiplatelet agents disclosed by Mitsui Toatsu
Read More
Merck KGaA prepares cardioprotective agents
Read More
PGE1 derivatives for peripheral circulatory disorders from Ono
Read More
Meiji Seika describes potent, broad-spectrum carbapenems
Read More
PLC-inhibitory peptides from Kyowa Hakko
Read More
Connaught prepares Bordetella vaccine
Read More
Alfacell elucidates action of Onconase
Read More
ACAT inhibitors from Nihon Nohyaku
Read More
Roche reveals cephalosporins
Read More
Princeton and Lilly disclose nonclassical antifolates
Read More
First launch for Lipobay
Read More
Endocrine tumor gene identified by NIH team
Read More
Yamanouchi describes potent and selective steroid 17,20 lyase inhibitor
Read More
BASF selects dual D4/5-HT2 antagonist for clinical development
Read More
FDA clears Epivir under traditional regulations; clinical benefit confirmed
Read More
ImmunoGen's novel anticancer agent eradicates a human cancer in mice
Read More
ProScript licenses cell cycle regulation technology from Harvard Medical School
Read More
Alza and SmithKline Beecham sign new agreement for Nicoderm
Read More
Astra Arcus develops selective CCK-A agonist with potential for obesity
Read More
U.S. patent approval for Theratechnologies' antisense therapy
Read More
Orally bioavailable cyclic HIV protease inhibitors with low potential for drug resistance
Read More
EntreMed produces recombinant Angiostatin
Read More
Pfizer discovers potent, selective beta3-adrenoceptor full agonist
Read More
Balanced ETA/ETB antagonist from Abbott
Read More
New selective estrogen receptor modulator from Lilly
Read More
ID Biomedical reports positive results for rapid test for VRE
Read More
AutoImmune freezes development of Myloral
Read More
Company Profile: DGI BioTechnologies
Read More
Company Profile: CDR Therapeutics
Read More
Gensia Sicor and Sankyo collaborate in diabetes research
Read More
Agouron and Nastech to develop common cold treatment
Read More
IVAX presents promising preclinical results with Elmiron
Read More
Isis Pharmaceuticals initiates phase III trials of its antisense drug for Crohn's disease
Read More